Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is among the cancer types with poorest prognosis and survival rates primarily due to resistance to standard-of-care therapies. including gemcitabine (GEM) and olaparib. Particularly. wild-type (wt)BRCA tumours. https://www.nacrack.com/flash-choice-Netgear-Nighthawk-LTE-Mobile-Hotspot-Router-Mobile-Hotspot-LTE-BRAND-NEW-p8608-best-super/